FIGURE 2
FROM:
Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer
M K Oehler, D C Fischer, M Orlowska-Volk, F Herrle, D G Kieback, M C P Rees and R Bicknell
BACK TO ARTICLEFigure 2.

Immunostaining of breast carcinomas with the anti-ADM monoclonal antibody 171. (A) Moderate staining (
100), (B) weak staining (
100), (C) strong staining (
200), (D) moderate staining (
400), (E) moderate staining (
1000), (F) strong staining (
1000). (Brown indicates immunostaining.)
